Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 05, 2018
The Lubrizol Corporation announces it will invest more than $25 million in its Calvert City, Kentucky manufacturing facility.
read more
Tuesday, February 05, 2019
Pharm-Olam is now enrolling patients in the U.S. and Europe into a pivotal Phase III study within the treatment of short bowel syndrome (SBS).
read more
The maker of a prescription fish-oil pill won an early victory Friday against the Food and Drug Administration over its right to publicize unapproved uses of its drug.
read more
Friday, February 28, 2020
American Health Packaging has voluntarily recalled 11 lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters to the consumer level due to the potential NDMA amounts above levels established by the FDA.
read more
WPD has entered into a development agreement with CNS for the development of several preclinical drug candidates including WP1122, which will be tested on a range of viruses including the coronavirus SARS-CoV-2.
read more
Biokin Pharmaceutical and Cryoport announced Cryoport's temperature-controlled solutions will support Biokin Pharma's pending Phase I and II clinical trials in immuno-oncology in both the U.S. and China.
read more
Pharmatech Associates, a regulatory compliance consultancy serving companies in the pharmaceutical, biotech and medical device industries, will lead training sessions on Quality by Design (QbD) and the new Process Validation (PV) requirements at the ...
read more
TriNetX has announced the signing of a collaboration agreement with Novartis to optimize clinical trial design and advance clinical research for Novartis programs.
read more
Thursday, November 21, 2019
Onconova have entered into a Distribution, License and Supply Agreement with Knight Therapeutics will have the exclusive rights to commercialize rigosertib in Canada.
read more
Virginia Governor Ralph Northam announced that Panaceutics will invest $5.8 million to establish a research and development and high-tech manufacturing facility.
read more
Wednesday, February 06, 2019
Amplicare announced the addition of two new benefits to its suite of solutions aimed at helping pharmacists improve patient care and health outcomes.
read more
Monday, September 18, 2017
Brammer Bio announced completion of its clinical capacity expansion in Alachua, Florida.
read more
Tuesday, February 27, 2024
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced positive top-line results from the company's Phase 2 clinical trial of VK2735, a dual ...
read more
Wednesday, October 15, 2025
Sterling Pharma Solutions announced Karl Rotthier as CEO, effective October, 21st. Rotthier succeeds Kevin Cook, who has served as CEO since 2013 and has now taken the decision to retire. Kevin will work closely with Karl to ensure a smooth ...
read more
Thursday, February 07, 2019
Perrigo has received final approval from the FDA for its AB rated Abbreviated NDA referencing Zovirax Cream, 5% (acyclovir cream, 5%) developed in collaboration with Sol-Gel Technologies.
read more